Hangzhou Coco Healthcare Products Co.,Ltd. (SHE:301009)
China · Delayed Price · Currency is CNY 8.73
-0.03 (-0.34%)
Jun 18, 2026, 9:55 AM CST
SHE:301009 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 2,334 | 3,378 | 2,848 | 2,898 | 3,262 | 5,016 | |
Market Cap Growth | -46.22% | 18.62% | -1.72% | -11.17% | -34.96% | - |
Enterprise Value | 1,659 | 2,680 | 2,170 | 2,195 | 2,612 | 4,379 |
Last Close Price | 8.76 | 12.68 | 10.64 | 10.50 | 11.82 | 18.06 |
PE Ratio | 116.27 | 93.53 | 91.36 | 143.57 | - | 126.20 |
Forward PE | - | 97.54 | 92.96 | 29.61 | 39.34 | 27.44 |
PS Ratio | 2.01 | 2.94 | 2.64 | 2.68 | 2.75 | 4.23 |
PB Ratio | 1.64 | 2.38 | 2.02 | 2.00 | 2.28 | 3.33 |
P/TBV Ratio | 1.87 | 2.70 | 2.27 | 2.25 | 2.57 | 3.78 |
P/FCF Ratio | 62.33 | 38.89 | - | 17.92 | - | - |
P/OCF Ratio | 22.26 | 26.65 | 54.31 | 12.73 | - | 99.27 |
EV/Sales Ratio | 1.43 | 2.33 | 2.01 | 2.03 | 2.20 | 3.69 |
EV/EBITDA Ratio | 21.81 | 33.39 | 38.24 | 38.05 | 140.96 | 53.08 |
EV/EBIT Ratio | 121.26 | 119.81 | 1152.24 | 552.55 | - | 129.08 |
EV/FCF Ratio | 44.30 | 30.85 | - | 13.58 | - | - |
Debt / Equity Ratio | 0.12 | 0.15 | 0.08 | 0.01 | 0.00 | 0.00 |
Debt / EBITDA Ratio | 2.20 | 2.49 | 1.85 | 0.30 | 0.23 | 0.08 |
Debt / FCF Ratio | 4.46 | 2.41 | - | 0.11 | - | - |
Net Debt / Equity Ratio | -0.53 | -0.56 | -0.53 | -0.58 | -0.48 | -0.58 |
Net Debt / EBITDA Ratio | -10.45 | -9.88 | -13.25 | -14.64 | -36.96 | -10.64 |
Net Debt / FCF Ratio | -20.19 | -9.13 | 32.81 | -5.23 | 4.46 | 4.62 |
Asset Turnover | 0.55 | 0.54 | 0.53 | 0.55 | 0.59 | 0.66 |
Inventory Turnover | 6.54 | 6.26 | 6.75 | 6.06 | 6.20 | 6.91 |
Quick Ratio | 1.71 | 1.73 | 1.74 | 2.19 | 2.02 | 1.88 |
Current Ratio | 1.99 | 1.97 | 2.03 | 2.48 | 2.44 | 2.21 |
Return on Equity (ROE) | 1.52% | 2.63% | 2.14% | 1.23% | -3.83% | 3.60% |
Return on Assets (ROA) | 0.40% | 0.66% | 0.06% | 0.13% | -1.28% | 1.19% |
Return on Invested Capital (ROIC) | 2.11% | 3.29% | 0.28% | 0.54% | -5.99% | 6.46% |
Return on Capital Employed (ROCE) | 0.90% | 1.50% | 0.10% | 0.30% | -2.80% | 2.20% |
Earnings Yield | 0.83% | 1.07% | 1.09% | 0.70% | -1.32% | 0.79% |
FCF Yield | 1.60% | 2.57% | -0.80% | 5.58% | -4.71% | -3.79% |
Dividend Yield | 1.33% | 0.95% | 0.66% | 0.71% | - | 0.39% |
Payout Ratio | 103.99% | 56.00% | 64.60% | - | - | 2.22% |
Buyback Yield / Dilution | 0.29% | 0.69% | 9.91% | -6.98% | -15.29% | -14.71% |
Total Shareholder Return | 1.63% | 1.63% | 10.57% | -6.26% | -15.29% | -14.32% |